ORIGINAL CONTRIBUTION
‘ensonomation, black
linical Presentation and Treatment of Black
Widow Spider Envenomation: A Review of 163 Cases
cdo spider
From the Department of Medical Richard Flak, MO
‘Tosicology, Cood Samaritan ‘Susan Wethern-Kestnr, BN
Regional Medical Centr, ‘Michael V Vance, MD
Phornis, Arizona. Richard Gerkin, MO
Revive for publication
June 10,1991. Revi
Decomber 2, 1001. Accepted for
publication Decomber 17,1991,
mn recived
Provented et the Society
for Academic Emergency
Medicine Annual Meeting in
Washington, DC, May 1991
Auer 1962. 21.7 ANNALS OF EMERGENCY MEDICINE
Study objective: To review cases of black widow spider envenoma-
tion to describe the clinical presentation and evaluat the efficacy of
treatment
Design: Retrospective chart review,
Setting: An urban toxicology referral contr.
‘Type of participants: Al patients attended by the toxicology ser-
vice and discharged from our hospital between January 1982 and
December 1990 with a diagnosis of black widow spider envenamation
Interventions: Inclusion criteria wore site 2 positive black widow
spidor identification ra visible envenomation sie "targa lesion”)
Depending on the clinical presentation, pationts were categorized as
grace 1,2, orn severity. The eicacy and side effects of treatment
altomatives were evaluate.
Measurements and main results: One hundted shty:tivee
patients met the inclusion criteria, The most common sites of envenc-
mation were the upper and lowes exemites. The mast camon pe-
senting complaint was generalized abdominal back, nd eg pain One
hundred eighteen patents italy presented to our insttion, and 45
were transfers. Pain elit of grade 2 and 3 envenomations was
achioved most effectively wit either black widow spder- specific
antivenn alone or combination of W opioids and muscle relaxants.
Fity-eight patents received antivenin wit complete resolution of
symtoms ina mean time of 31 £26.7 minutes. Of the 118 patients
iialy sen at our institution, the mean total dation of symptoms
was 9++227 hous in patients reelvng antvenin ard 22 +249 hous
inpatients not receiving ativenin, Fity-two percent of patients not
‘eceivingantiveninrequited hospitalization, whereas only 12% of those
receiving antvenin wer admitted, One patient died of severe bron-
chospasm after receiving antverin,Caleium gluconate was not effoc-
tivein providing symptomatic eli inthis series, with 95% of the
ade 2 and 3 envenomation treated italy with calcium gluconate
‘quiring the ation of V opioid o other analgesics for symptomatic
tli. ity-five percent of patients intalyeciving WY morphine and
70% of those italy receiving both V morphine and benzodiazepines
obtained symptomatic relief without atonal medicationENVENOMATION
lark eal
Conclusion: One hundred sity-three envenomation by black widow
riders were reviewed and graded according to severty wit treatment
‘modalities evaluated. Although calcium gluconate usually has bean con-
sidered the ist-lne treatment of severe envenomation by black widow
spiders, we found itineffecive for pain rei compeed with a combina-
tion of V opioids and benzodiazepines. The use of antiverin significantly
shortened the duration of symotams in severe envenomations.
[Clark FF, Wether-KestnerS, Vance MN, Gorn: Clinical presentation
‘and treatment of black widow spider envenomation: A review of 163,
cases, Ann Emerg Mod July 1982:21:782-787,]
INTRODUCTION
Superstitions surrounding spiders were reported in Greek
mythology. when the jealous goddess Aphrodite transformed
Arachne into a spider. In the 17th eentury, southern Europe:
experienced a panic over the bite of a spider that is thought
to have been a type of wolf spider, Lycosa tarantula, and a
dance ealled a “tarantella” was devised to protect bite victims.
“Much of the folklore concerning bites by large hairy spiders
(most of which are harmless) originated from this era. Medical
reports of spider bites during this period proclaimed to be
from tarantulas more likely were from Latrodectus tredecim-
_guttatus, a European species related to the North American
Dlack widow.
Black widow spiders (Latrodectus sp) produce one of the
‘most potent known venoms by volume.? The venom is chiefly
a ncurotoxin in human beings, with symptoms most often
ranifested as severe skeletal muscle pain and cramping’ and
autonomic disturbances such as diaphoresis and hyperten-
ion.3 A variety of treatments have heen tried for sever
Latrodectus cavenomations. Muscle relaxants, TV ealeium
eluconate, opioids, and Latrodectus-specilie antivenin hay
heen used with reported suecess.?7 Small studies have been,
undertaken to assess the efficacy of therapy.# but the
gue
‘Typical target lesion, demonstrotng the contrl puncte ste of envenomation, @
surrounding are of aching, andthe outer erythematous ring
poyvea
authors could draw no conclusions. We retrospectively
reviewed 163 eases of envenomations by black widow spiders
to deserihe the elinical presentation and evaluate the efficacy
of treatment.
MATERIALS AND METHODS
‘The charts of 172 consecutive patients with a diagnosis of
black widow spider envenomation directly managed by the
toxicology service of an urban hospital and regional toxicology
referral center from January 1982 through December 1990
were reviewed retrospectively. The species of black widow
found in Arizona is Latrodectus hesperus (LH), bites of which
are clinically similar to those reported with the more ubiqui-
tous Latrodectus mactans and Latrodectus variolus.? Venom
from Latrodectus mactans and Latrodectus hesperus are s0
structurally similar that cnvenomations by each would be
expected to respond similarly to various treatment regimens 10.1
Inclusion eriteria for entry into the study were either &
positive Lil identification by the patient (or hospital staff
when the spider was brought to the emergency department)
or the presence of an erythematous envenomation site or
“target lesion” (Figure 1) on physical examination associated
with characteristic symptoms of envenomation. We have
found the target lesion a reliable sign of LH envenomation, 12
Each chart was reviewed for data pertaining to patient age,
“anatomic location of the bite, time and circumstances of the
bite, vital signs, presenting complaint, physical examination
finaings, total duration of symptoms, laboratory results,
transfer data from referral facilites, and treatment includ-
ing outcome and adverse reactions. “Relief of symptoms”
‘was defined as subjective pain relief as recorded in each,
patient's medical record for 30 minutes or longer after treat-
ment administration, We divided study patients into grade
Tabi
Grading ele often and symptoms flowing Latrodectas envenomatons
rade __Descripden Tatlin Series (3)
1 Asymptomatic 0)
cal sin at envenomation ste
Nova sane
2 Musa pin in rvononstog
avery
Emanion of muscular paint abdomen
‘envenomatd on lover aan,
renee envanomated 0 oper amity
Local daphoress of enerometon site or
Inte extremity
Nomal va sgne
in
a Generalized muscle pain in back,
abdomen, nd chest
Diphorsiaremote om enverarnon ste
Abnormal vel sis
ypartnsion sto lead prssure> 10mm Hp
(aso ood pressure» arm Ho
‘Techyardia (pase >100)
ses an vrtig
Headache
89
ANNALS OF EMERGENCY MEDICINE 21:7. SULY 1982ENVENOMATION
Clark eeat
was based on the remai
Retrospective follow-up information concerning delayed
hypersensitivity reactions was sought on all patients receiv
ing antivenin. All patients receiving antivenin at ou
tion are educated extensively eon i
associated with delayed hypersensitivity reactions such
rashes, myalgias, pruritus, and fever. Each patient (o
‘accompanying parent for children) was requested to notify
the poison center if signs or symptoms of delayed hypersensi-
tivity reactions were observed so that the patient could be
re-evaluated or preseriptions ordered if needed. Follove-up
data concerning these reactions were recorded by the poison
center, and these data were reviewed on paticnts treated
since 1986 for any observed and reported delayed hypersen-
sitivity reactions, In addition, telephone follow-up was
aitempted to all patients who received antivenin.
Sued analy wan performed using Stade tse
and 2 analysi
ing criteria
RESULTS
One hundred seventy-two charts with the
widow spider envenomation” were reviewed
inclusion eiteria. Ninety-nine patients (61%) were male
Ninety-four patients (58%) were bitten at their residence,
and 24 (159%) were bitten by a spider Uhat was in thei eloth-
ing or shoes as thoy dressed. Sixteen pationts (6%) were bit
ten in bed. The average age ofall patients was 31.6 years,
with an age range of 8 months to 88 years. The stuly group
included 18 pediatric patients.
A positive identification of the spider was recorded in 117
charts (7296), whereas a target lesion was mentioned among
the recorded physical examination in 79 patients (4896).
Patients most often were hitten on the lower extremity
(Figure 2). The average time from envenomation until onset
of symptoms was 1.15 £ 1.64 hours (ranging from immediately
to [2 hours). The average time from onset of symptoms until
presentation to a health eare facility for all patients wax
6,157.83 hours (range, 30 minutes to 48 hours).
liagnosis of “black
ind 163 met
Fowe2
Lectons of Latredet hesperus ncenmaton
No.of Paionts
JULY 1882. 21:7. ANNALS OF EMERGENCY MEDICINE
‘The most common presenting complaint was genes
‘muscular abdominal, back, and leg pain, altho
of complaints were recorded (Figure 3). Thirty
(22%) were diaphoretc on presentation, Most adult vietims
presented with normal vital signs, but 45 (31%) were hyper-
tensive (systolic blood pressure, 140 mm Hg, er diastolic
(10%) presented with tachycardia (pulse 100).
‘The majority of all envonomations were grade 2 (87%) and
3 (5496) in severity (Table 1). Kighty-nine male vietims (90%)
and 59 female victims (92%) were grade 2 or 3 envenoma-
tions. Eighty grade 2 or 3 patients (54%) were 31 years old
or younger.
‘Twenty-two patients (149) in this series initially were sent
home after evaluation in an ED or physician's office but
returned to an ED with recurring pain. One hundred eighteen
patients (72%) in the study initially were seen at our institu-
tion. Forty-five patients (28%) were transferred to our insti-
tution from another facility due to treatment failures of
rade 2 or 3 envenomations. Of the 45 transferred patients,
15 (88% of those transferred) had reeeived either ealeium
eluconate alone or in combination with a muscle relaxant such,
asmethocarbamol. Only six (139) had received a trial of TV
‘or IM opioids. The remainder of patients had received some
combination of oral analgesics, TV muscle relaxants, or other
therapies. None had received antivenin.
Laboratory testing was performed on some severe enveno-
‘mations (Table 2). Twenty-one of 54 patients with laboratory
‘work performed had abnormal laboratory findings, the mast
‘common being leukocytosis. Although 38 patients with severe
and cramping were evaluated with total ereatine
evels, only seven were found to have elevat
ced values (highest, 1,350; mean, 718 IU/L). Myoglobinuria
aluated
gure
Common signs and symptoms asscated
i =
se